sur Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at the September 9-11 H.C. Wainwright Annual Global Investment Conference
San Francisco-based Jaguar Health, Inc. (NASDAQ:JAGX) announced today that its founder, president, and CEO, Lisa Conte, will present virtually at the H.C. Wainwright 26th Annual Global Investment Conference. The event will be held from September 9-11, 2024.
Conte will offer an on-demand virtual presentation accessible starting at 7:00 AM Eastern on Monday, September 9, 2024. The conference will take place both virtually and in-person at Lotte New York Palace, New York City.
Jaguar Health focuses on developing proprietary prescription medicines derived from plants for treating gastrointestinal distress in humans and animals. Its subsidiaries, Napo Pharmaceuticals and Napo Therapeutics, work on commercializing these medicines and expanding their availability in Europe. Magdalena Biosciences focuses on mental health treatments derived from plants.
R. E.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Jaguar Health, Inc.